Navigation Links
Enerkem appoints new Chief Financial Officer
Date:2/18/2010

MONTREAL, Feb. 18 /PRNewswire/ - Enerkem Inc., a leading waste-to-biofuels and advanced chemicals technology company, today announced that Mr. Patrice Ouimet has joined the company as Vice-President and Chief Financial Officer.

Mr. Ouimet brings a wealth of knowledge to Enerkem's current seasoned team of executives, with substantial experience in corporate strategy, corporate development and investment banking. Prior to joining Enerkem, Mr. Ouimet was Vice-President, Corporate Development and Enterprise Risk Management for Gildan Activewear, an international apparel manufacturer and marketer. As a Chartered Accountant, Mr. Ouimet began his career with Ernst & Young. He later worked in the investment banking sector, where he provided strategic and financial advice on mergers and acquisitions as well as capital markets transactions to a diversified client base, primarily in the industrial and paper & forest products sectors. Mr. Ouimet was Director, Mergers and Acquisitions at Lazard and Director, Investment Banking at CIBC World Markets.

"I am thrilled to welcome Patrice Ouimet to Enerkem. He is an experienced finance executive and his knowledge of capital markets transactions and manufacturing brings valuable skill sets to our company," said Vincent Chornet, President and Chief Executive Officer of Enerkem. "Mr. Ouimet's versatile experience will prove to be a great asset for Enerkem, as a growing company that is fast becoming a leader in an even faster developing advanced biofuels industry."

About Enerkem

Enerkem is a leading waste-to-biofuels company. Its proprietary thermo-chemical technology converts residual materials, such as non-recyclable municipal solid waste, into clean transportation fuels, advanced chemicals and electricity. The company was founded in 2000 and currently operates two plants in Canada: a pilot facility in Sherbrooke and a commercial-scale plant in Westbury. It will soon start the construction of a waste-to-biofuels plant in Edmonton, Canada, and is currently developing a similar project in Mississippi, for which it was awarded US$50 million in funding by the U.S. Department of Energy (DOE). www.enerkem.com

/NOTE TO PHOTO EDITORS: A photo accompanying this release is available at http://photos.newswire.ca. Images are free to accredited members of the media/

SOURCE Enerkem Inc.


'/>"/>
SOURCE Enerkem Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Enerkem Awarded $50 Million Funding by U.S. Department of Energy for its Mississippi Biorefinery Project
2. Enerkem Named an Emerging Cleantech Leader in Canada
3. Enerkem Announces Unique Community Energy Project
4. Enerkem Announces Construction Start on Advanced Energy Research Facility in Edmonton, Alberta
5. Enerkem Announces World-Class Advanced Energy Research Center in Edmonton, Alberta, Canada
6. Enerkem GreenField Alberta Biofuels Awarded Permit to Build Worlds First Commercial Municipal Waste-to-Biofuels Facility
7. Enerkem announces plans to enter the United States with next-generation biofuels project in Mississippi
8. Enerkem announces first commercial-scale biofuels and biochemicals plant is entering start-up phase
9. Enerkem Expands Executive Management Team
10. GreenField Ethanol and Enerkem Announce Plans to Make Cellulosic Ethanol a Commercial Reality
11. Enerkem announces progress on construction of Canadas first cellulosic ethanol plant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... MILFORD, Mass. , March 23, 2017 ... leading partner to global in vitro diagnostics ... launch of the industry,s first multiplexed ... inherited disease testing by next-generation sequencing ... materials were developed with input from industry ...
(Date:3/23/2017)... NetworkNewsWire Editorial Coverage  ... Cancer remains one of ... health care systems, in terms of costs and resources. However, ... the development of innovative and efficient therapies that demonstrate higher ... types of cancer treatments, a growing number of patients receiving ...
(Date:3/22/2017)... , March 22, 2017 Regeneron Pharmaceuticals, Inc. (NASDAQ: ... Genetics Center (RGC), U.K. Biobank and GSK to generate genetic ... Biobank resource. The initiative will enable researchers to gain valuable ... for a wide range of serious and life threatening diseases. ... Genetic ...
(Date:3/22/2017)... March 22, 2017 Oramed Pharmaceuticals Inc. ... www.oramed.com ), a clinical-stage pharmaceutical ... delivery systems, announced today that Dr. Miriam ... a presentation titled, "Oral Insulin for Diabetes Treatment: ... Healthtech Institute,s Oligonucleotide and Peptide Therapeutics (OPT) Boston Conference in ...
Breaking Biology Technology:
(Date:3/16/2017)... , March 16, 2017 CeBIT 2017 - Against identity fraud with ... Reading ... Used combined in one project, multi-biometric solutions provide a crucial ... Used combined in ... ...
(Date:3/7/2017)... , March 7, 2017   HireVue , the ... global companies identify the best talent, faster, today announced ... Sales Officer (CSO) and Diana Kucer as ... out a seasoned executive team poised to drive continued growth ... on a year of record bookings in 2017. ...
(Date:3/2/2017)... , March 2, 2017 Australian stem ... (ASX: CYP), has signed an agreement with the ... the Monash Biomedicine Discovery Institute and Department of Pharmacology ... conduct a further preclinical study to support the use ... of asthma.  Asthma is a chronic, ...
Breaking Biology News(10 mins):